Clinical Trial Update: COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

View source ↗

Summary

A prospective registry to determine the prevalence of myocarditis and pericarditis following COVID-19 vaccination, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis
• Pericarditis

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Myocarditis, Pericarditis | Status: RECRUITING